Goodluck Willey Lyatuu

Goodluck Willey Lyatuu

Auto-generated profile, based on publicly available information

Goodluck Willey Lyatuu

Programs, Management and Development for Health, Dar es Salaam, Tanzania, United Republic of

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in The Lancet HIV
Verified
Journal Article
Closed access
GLGoodluck W Lyatuu
Goodluck W Lyatuu
SMShally Z Mwashemele
Shally Z Mwashemele
RURoseline Urrio
Roseline Urrio
HNHelga Naburi
Helga Naburi
NKNassir Kashmir
Nassir Kashmir
AEAnna Mia Ekström
Anna Mia Ekström

9 March 2022 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
GLGoodluck Willey Lyatuu
Goodluck Willey Lyatuu
HNHelga Naburi
Helga Naburi
SMShally Mwashemele
Shally Mwashemele
PLPeter Lyaruu
Peter Lyaruu
RURoseline Urrio
Roseline Urrio
AEAnna Mia Ekström
Anna Mia Ekström
Peer support services are increasingly being integrated in programmes for the prevention of mother-to-child HIV transmission (PMTCT). We aimed to evaluate the effect of a peer-mother interactive programme on PMTCT outcomes among pregnant women on anti-retroviral treatment (ART) in routine healthcare in Dar es Salaam, Tanzania. Twenty-three health facilities were cluster-randomized to a peer-mother intervention and 24 to a control arm. We trained 92 ART experienced women with HIV to offer peer education, adherence and psychosocial support to women enrolling in PMTCT care at the intervention facilities. All pregnant women who enrolled in PMTCT care at the 47 facilities from 1st January 2018 to 31st December 2019 were identified and followed up to 31st July 2021. The primary outcome was time to ART attrition (no show >90 days since the scheduled appointment, excluding transfers) and any difference in one-year retention in PMTCT and ART care between intervention and control facilities. Secondary outcomes were maternal viral suppression (<400 viral copies/mL) and mother-to-child HIV transmission (MTCT) by ≥12 months post-partum. Analyses were done using Kaplan Meier and Cox regression (ART retention/attrition), generalized estimating equations (viral suppression) and random effects logistic regression (MTCT); reporting rates, proportions and 95% confidence intervals (CI). There were 1957 women in the peer-mother and 1384 in the control facilities who enrolled in routine PMTCT care during 2018–2019 and were followed for a median [interquartile range (IQR)] of 23 [10, 31] months. Women in both groups had similar median age of 30 [IQR 25, 35] years, but differed slightly with regard to proportions in the third pregnancy trimester (14% versus 19%); advanced HIV (22% versus 27%); and ART naïve (55% versus 47%). Peer-mother facilities had a significantly lower attrition rate per 1000 person months (95%CI) of 14 (13, 16) versus 18 (16, 19) and significantly higher one-year ART retention (95%CI) of 78% (76, 80) versus 74% (71, 76) in un-adjusted analyses, however in adjusted analyses the effect size was not statistically significant [adjusted hazard ratio of attrition (95%CI) = 0.85 (0.67, 1.08)]. Viral suppression (95%CI) was similar in both groups [92% (91, 93) versus 91% (90, 92)], but significantly higher among ART naïve women in peer-mother [91% (89, 92)] versus control [88% (86, 90)] facilities. MTCT (95%CI) was similar in both groups [2.2% (1.4, 3.4) versus 1.5% (0.7, 2.8)]. In conclusion, we learned that integration of peer-mother services in routine PMTCT care improved ART retention among all women and viral suppression among ART naïve women but had no significant influence on MTCT.

12 December 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GLGoodluck Willey Lyatuu
Goodluck Willey Lyatuu
HNHelga Naburi
Helga Naburi
RURoseline Urrio
Roseline Urrio
SMShally Zumba Mwashemele
Shally Zumba Mwashemele
SMSarah Mdingi
Sarah Mdingi
AEAnna Mia Ekström
Anna Mia Ekström
Male partner participation improves uptake, retention and outcomes of prevention of mother-to-child transmission of HIV (PMTCT) services. However, in patriarchal settings few men accompany their partners to antenatal care (ANC) and PMTCT services. We explored whether community leaders can improve male partner participation in ANC and PMTCT. We integrated initiatives to increase male partner participation in routine ANC care in six health facilities (attending about 4,500 new pregnant women per quarter) in Dar es Salaam, Tanzania in 2015/16. These initiatives were adapted from a best performing health facility, on male partner participation in ANC and PMTCT, referred to as the “best practice site”. At the six purposively selected intervention sites, we sensitized and garnered commitment from healthcare providers to provide couple friendly services. We then worked with the providers to sensitize and engage community leaders to integrate and promote male partner participation initiatives in their routine community activities. We assessed change in male partner participation in ANC and PMTCT using the proportion of women testing for HIV together with their partners (i.e. couple HIV testing) by quarter. We used 203 ANC facilities (attending about 31,000 new pregnant women per quarter) in the same area as control sites. After one year, couple HIV testing in the six intervention sites had tripled from 11.9% at baseline to 36.0% (p<0.001) while there was very little change (from 17.7% to 18.3%) in the 203 control sites (p = 0.07). Statistically significant improvements in couple testing were observed in four of the six intervention sites (6.7% to 19.1%; 9.3% to 74.6%; 46.2% to 95.2%; and 4.7% to 15.1% respectively. p<0.001 for all sites). Two of these four sites, located in the same administrative district as the best practice site, achieved remarkably high couple HIV testing (95.2% and 74.6%). This may be attributable to the greater engagement and active participation of the community leaders in these two sites compared to the other four. Effective engagement and functional partnerships between healthcare providers and community leaders can contribute to improve male partner participation in ANC and PMTCT services. PMTCT programs should capitalize on community leaders, in addressing low male partner participation in ANC and PMTCT, in order to improve effective uptake, retention and outcomes of HIV prevention and treatment services among pregnant and breastfeeding women, their partners, infants and families.

27 April 2026 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
RURoseline F. Urrio
Roseline F. Urrio
GLGoodluck Willey Lyatuu
Goodluck Willey Lyatuu
CFCharles Festo
Charles Festo
HNHelga Naburi
Helga Naburi
DMDaima Machang’U
Daima Machang’U
AEAnna Mia Ekström
Anna Mia Ekström
This large cohort study examines long-term trends and predictors of viremia among pregnant and postpartum adolescent girls and young women (AGYW) living with human immunodeficiency virus (HIV) in Tanzania. This prospective cohort study included 7703 pregnant/postpartum AGYW with at least one viral load (VL) enrolled in routine prevention of mother-to-child transmission (PMTCT) care between 2018 and 2020 across three regions in Tanzania and followed for a minimum of 36 months. Poisson generalized linear models with a log link function were used to estimate adjusted incidence rate ratios and 95% confidence intervals for detectable viremia (VL ≥50 copies/mL) by baseline exposures. Over three years, detectable viremia was highest among the youngest age group 15-17 years (20.4%) compared with those aged 18-19 (16.7%) and 20-24 years (12.5%). Viremia declined during pregnancy but plateaued postpartum, with >10% of participants remaining viremic. Perinatally infected AGYW (HIV diagnosis at age ≤12 years) had higher rates of viremia (28.8%) than those already receiving antiretroviral therapy (ART) (11.0%) or newly initiated on ART (15.2%) who were diagnosed after childhood. Over 25% of perinatally infected AGYW remained viremic throughout the PMTCT cycle. Second-line ART and urban residence were associated with higher risk of viremia. Persistently high viremia was observed over time among Tanzanian pregnant/postpartum AGYW with HIV, particularly adolescents and those with perinatally acquired infection. Tailored PMTCT interventions, including resistance-informed treatment and youth-friendly adherence support, are needed to improve maternal outcomes and accelerate elimination of vertical transmission.

18 June 2026 in BMJ Open
Verified
Journal Article
Open access
PDF file
GLGoodluck Willey Lyatuu
Goodluck Willey Lyatuu
ELElin C Larsson
Elin C Larsson
HSHellen Siril
Hellen Siril
TMTheodora Mbunda
Theodora Mbunda
RURoseline F Urrio
Roseline F Urrio
AKAnna E Kågesten
Anna E Kågesten
Introduction Sub-Saharan Africa (SSA), including Tanzania, is double-burdened with high rates of teenage pregnancy and new HIV infections among adolescent girls and young women (AGYW) aged 15–24 years. Moreover, pregnant AGYW living with HIV in SSA have poorer adherence and retention on HIV treatment and elevated risks of vertical HIV transmission to their infants, as compared with older women. This paper describes the methods for the ENGAGE project, aiming to investigate and optimise healthcare for prevention of vertical HIV transmission (commonly prevention of mother-to-child transmission (PMTCT)) for AGYW living with HIV in Tanzania. Methods and analysis ENGAGE uses a mixed-methods design to co-create and prototype an intervention package for pregnant/postpartum AGYW living with HIV through three phases in three Tanzanian regions. Phase 1 characterises the problem by investigating care engagement and outcomes in a cohort of N=10 147 AGYW receiving PMTCT services in routine healthcare. Phase 2 uses qualitative interviews to understand the social-structural drivers of care engagement from the perspective of AGYW, healthcare providers and community stakeholders and an evidence review of potential solutions. In phase 3, we will use findings from phase 1 and 2 to co-create (together with AGYW and healthcare providers) an intervention package to optimise PMTCT care for most at-risk AGYW. The co-creation will be done through an intervention development action cycle, where ideas are presented, feedback sought and refinements made iteratively via several workshops over about 6 months. The resulting co-created intervention package will be prototyped at selected facilities/communities and refined into a final version, ready for piloting for feasibility, acceptability and preliminary effect in a later phase. This protocol focuses on the co-creation phase 3 and its preceding phases 1 and 2. Ethics and dissemination ENGAGE has received ethical approval from the Tanzania National Health Research Ethics Committee (NIMR/HQ/R.8a/Vol.IX/4637), and the Swedish Ethical Review Authority (2024-05745-01) for analysis of data in Sweden. Findings will be disseminated to AGYW, healthcare providers, community stakeholders, health officials, researchers, policy makers and the wider local and global scientific community.

21 April 2026 in BMJ Open
Verified
Journal Article
Open access
RURoseline F Urrio
Roseline F Urrio
LMLameck Machumi
Lameck Machumi
HNHelga Naburi
Helga Naburi
MMMichael J Mahande
Michael J Mahande
CFCharles Festo
Charles Festo
GLGoodluck Willey Lyatuu
Goodluck Willey Lyatuu
Objectives: To examine HIV care attrition patterns and risk factors among adolescent girls and young women (AGYW) enrolled in prevention of mother-to-child transmission of HIV (PMTCT) services in Tanzania. Design: Prospective cohort study. Setting: The study was conducted in three regions of Tanzania: Kagera, Tabora and Dar es Salaam across 543 public and private health facilities. Participants: A total of 10 147 pregnant and postpartum AGYW living with HIV attending PMTCT services between 1 January 2018 and 31 December 2020 were included in this study and followed prospectively until they were censored at the last appointment date or 31 December 2023, whichever was earlier. Primary outcome measures: The primary outcome was time to HIV care attrition, defined as death, discontinuation of antiretroviral treatment (ART) or loss to follow-up (LTFU). LTFU was defined as failure to attend a scheduled clinic appointment and being absent from care for ≥90 consecutive days following a missed appointment among non-transfers. Kaplan-Meier analyses were used to estimate time to first attrition. The Anderson-Gill proportional hazard model estimated the risk factors for repeated care interruptions, adjusted for baseline characteristics and stratified by ART status at PMTCT enrolment. Results: A total of 3259 attrition events were observed, of which 79% occurred within the first year, with the median time to first attrition of 4 months (IQR: 1–8), 96.3% were due to LTFU. Over two-thirds of first-year attrition occurred among AGYW newly started on ART at PMTCT enrolment, who had more than twice the attrition rate of those already on ART (28.6 vs 11.2 per 100-person-years). Of AGYW lost to follow-up, 44.8% returned to care and 20.9% experienced subsequent attrition. Among AGYW new on ART, attrition was higher in those enrolled late in their third trimester (adjusted HR (aHR) 1.20; 95% CI 1.01 to 1.42) versus those in the first trimester and lower during the postpartum period (aHR 0.58; 95% CI 0.43 to 0.79). In AGYW already on ART, attrition rate was higher among adolescents 18–19 years (aHR 1.37; 95% CI 1.13 to 1.66) and those enrolled late; during the second (aHR 1.41; 95% CI 1.16 to 1.72) and third trimesters (aHR 1.57; 95% CI 1.23 to 2.00) or post partum (aHR 1.36; 95% CI 1.09 to 1.70) compared with the first trimester. AGYW with early-stage HIV, on second-line regimens and attending facilities with fewer AGYW, had a lower attrition rate in contrast to comparison groups. Conclusion: AGYW newly started on ART at PMTCT enrolment are more likely to have early and recurring dropout. Given the cyclical nature of HIV care engagement, tailored and repeated interventions are needed to support continuous retention and re-engagement for pregnant and postpartum AGYW with HIV.